ETH 416 (Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U)
Generic Name: pancrelipase
Pill with imprint ETH 416 is Tan, Round and has been identified as Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U. It is supplied by Ethex Corporation.
Plaretase is used in the treatment of pancreatic exocrine dysfunction; chronic pancreatitis; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U is not a controlled substance under the Controlled Substances Act (CSA).
Images for ETH 416
Plaretase
- Generic Name
- pancrelipase
- Imprint
- ETH 416
- Strength
- Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U
- Color
- Tan
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Digestive enzymes
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ethex Corporation
- National Drug Code (NDC)
- 58177-0416 (Discontinued)
More about Plaretase (pancrelipase)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug images
- Drug class: digestive enzymes
Patient resources
- Other brands
- Creon, Zenpep, Pancreaze, Pertzye, ... +5 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.